Patent: 9,657,292
✉ Email this page to a colleague
Summary for Patent: 9,657,292
Title: | Compositions and methods for treating or preventing lupus |
Abstract: | The invention features compositions comprising agents that inhibit or reduce self-reactive IgE and/or basophils, and related methods of using the compositions for treating or preventing lupus, lupus nephritis, and lupus-related disorders. |
Inventor(s): | Rivera; Juan (Mechanicsburg, PA), Charles; Nicolas (Asnieres sur Seine, FR) |
Assignee: | The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) |
Application Number: | 13/989,744 |
Patent Claims: | see list of patent claims |
Details for Patent 9,657,292
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2039-02-26 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2039-02-26 |
Genentech, Inc. | XOLAIR | omalizumab | For Injection | 103976 | 06/20/2003 | ⤷ Try a Trial | 2039-02-26 |
Genentech, Inc. | XOLAIR | omalizumab | Injection | 103976 | 09/28/2018 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |